文献速递脑血管病

肾功能对缺血性卒中患者再灌注治疗后短期结局的影响

Impact of Renal Function on Short-Term Outcome After Reperfusion Therapy in Patients With Ischemic Stroke.
PubMed 文献 · Stroke · 2022-09-21

这项前瞻性登记队列研究纳入2000年1月至2019年9月接受再灌注治疗的2266例缺血性卒中患者,按年龄和性别特异性eGFR的第5和第95百分位定义低eGFR和高eGFR。高eGFR组和低eGFR组6个月死亡率均独立高于正常eGFR组,肾功能可被视为再灌注治疗后预后因素。

要点

  • 高eGFR组6个月死亡24例(22.9%),低eGFR组37例(33.6%),正常eGFR组237例(11.6%)。
  • 校正单变量分析中P<0.10的变量后,高eGFR与6个月死亡率独立相关(HR 2.22,95%CI 1.36-3.62,P=0.001)。
  • 低eGFR与6个月死亡率独立相关(HR 2.29,95%CI 1.41-3.72,P=0.001),且不受治疗方式或基线特征影响。

核心结论

  • 高eGFR和低eGFR均与再灌注治疗后6个月死亡率独立相关。
  • 肾功能可被视为缺血性卒中患者再灌注治疗后的预后因素。

研究设计与样本

  • 前瞻性登记队列研究,纳入2000年1月至2019年9月接受再灌注治疗并登记于SECRET研究或Yonsei卒中队列的2266例患者。
  • 高和低eGFR基于慢性肾脏病流行病学协作组方程,分别定义为年龄和性别特异性eGFR的第5和第95百分位。
  • 根据eGFR将患者分为低、正常或高eGFR组,比较6个月内死亡发生情况。

主要发现

  • 2266例患者中,2051例(90.5%)eGFR正常,110例(4.9%)eGFR低,105例(4.6%)eGFR高。
  • 高eGFR组患者较其他组更年轻,高血压、糖尿病或心房颤动比例更低,活动性癌症更常见。
  • 6个月随访期间,高eGFR组死亡24例(22.9%),低eGFR组死亡37例(33.6%),正常eGFR组死亡237例(11.6%)。
  • 校正单变量分析中P<0.10的变量后,6个月死亡率与高eGFR独立相关(HR 2.22,95%CI 1.36-3.62,P=0.001),与低eGFR独立相关(HR 2.29,95%CI 1.41-3.72,P=0.001)。
  • 这些关联不受治疗方式或各种基线特征影响。

关键数值与推荐

  • 高eGFR定义为年龄和性别特异性eGFR的第95百分位,低eGFR定义为第5百分位,基于慢性肾脏病流行病学协作组方程。
  • 高eGFR组6个月死亡24例(22.9%),低eGFR组37例(33.6%),正常eGFR组237例(11.6%)。
  • 高eGFR与6个月死亡率:HR 2.22(95%CI 1.36-3.62),P=0.001。
  • 低eGFR与6个月死亡率:HR 2.29(95%CI 1.41-3.72),P=0.001。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A high and low estimated glomerular filtration rate (eGFR) could affect outcomes after reperfusion therapy for ischemic stroke. This study aimed to determine whether renal function based on eGFR affects mortality risk in patients with ischemic stroke within 6 months following reperfusion therapy. METHODS: This prospective registry-based cohort study included 2266 patients who received reperfusion therapy between January 2000 and September 2019 and were registered in the SECRET (Selection Criteria in Endovascular Thrombectomy and Thrombolytic Therapy) study or the Yonsei Stroke Cohort. A high and low eGFR were based on the Chronic Kidney Disease Epidemiology Collaboration equation and defined, respectively, as the 5th and 95th percentiles of age- and sex-specific eGFR. Occurrence of death within 6 months was compared among the groups according to their eGFR such as low, normal, or high eGFR. RESULTS: Of the 2266 patients, 2051 (90.5%) had a normal eGFR, 110 (4.9%) a low eGFR, and 105 (4.6%) a high eGFR. Patients with high eGFR were younger or less likely to have hypertension, diabetes, or atrial fibrillation than the other groups. Active cancer was more prevalent in the high-eGFR group. During the 6-month follow-up, there were 24 deaths (22.9%) in the high-eGFR group, 37 (33.6%) in the low-eGFR group, and 237 (11.6%) in the normal-eGFR group. After adjusting for variables with P<0.10 in the univariable analysis, 6-month mortality was independently associated with high eGFR (hazard ratio, 2.22 [95% CI, 1.36-3.62]; P=0.001) and low eGFR (HR, 2.29 [95% CI, 1.41-3.72]; P=0.001). These associations persisted regardless of treatment modality or various baseline characteristics. CONCLUSIONS: High eGFR as well as low eGFR were independently associated with 6-month mortality after reperfusion therapy. Kidney function could be considered a prognostic factor in patients with ischemic stroke after reperfusion therapy.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Park H, Kim YD, Nam HS, et al. Impact of Renal Function on Short-Term Outcome After Reperfusion Therapy in Patients With Ischemic Stroke. Stroke. 2022. PMID: 36128905. doi:10.1161/STROKEAHA.122.039129

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。